GR930300027T1 - - Google Patents

Info

Publication number
GR930300027T1
GR930300027T1 GR930300027T GR930300027T GR930300027T1 GR 930300027 T1 GR930300027 T1 GR 930300027T1 GR 930300027 T GR930300027 T GR 930300027T GR 930300027 T GR930300027 T GR 930300027T GR 930300027 T1 GR930300027 T1 GR 930300027T1
Authority
GR
Greece
Application number
GR930300027T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR930300027T1 publication Critical patent/GR930300027T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GR930300027T 1987-02-27 1993-05-24 GR930300027T1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (1)

Publication Number Publication Date
GR930300027T1 true GR930300027T1 (enExample) 1993-05-24

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930300027T GR930300027T1 (enExample) 1987-02-27 1993-05-24

Country Status (26)

Country Link
EP (1) EP0280571B1 (enExample)
JP (1) JPH082793B2 (enExample)
KR (1) KR960005140B1 (enExample)
CN (1) CN1023765C (enExample)
AR (1) AR243376A1 (enExample)
AT (1) ATE92309T1 (enExample)
AU (1) AU604849B2 (enExample)
CA (1) CA1316110C (enExample)
CY (1) CY1741A (enExample)
DE (2) DE280571T1 (enExample)
DK (1) DK175620B1 (enExample)
EG (1) EG18523A (enExample)
ES (1) ES2044825T3 (enExample)
GR (1) GR930300027T1 (enExample)
HK (1) HK125793A (enExample)
HU (1) HU202747B (enExample)
IE (1) IE61419B1 (enExample)
IL (1) IL85538A (enExample)
LV (1) LV10184B (enExample)
MX (1) MX10558A (enExample)
NZ (1) NZ223619A (enExample)
PH (1) PH24358A (enExample)
PT (1) PT86831B (enExample)
RU (1) RU1831337C (enExample)
UA (1) UA18251A (enExample)
ZA (1) ZA881301B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9106419A (pt) * 1990-05-04 1993-05-04 Perio Prod Ltd Sistema de liberacao colonica de medicamentos
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CN1137238A (zh) * 1993-10-22 1996-12-04 株式会社津村 一种持续释放药物制剂的基料，一种持续释放药物制剂，以及该药物制剂的一种生产方法
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
HU224035B1 (hu) * 1996-05-13 2005-05-30 Novartis Consumer Health S.A. Bukkális adagolórendszer
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
ATE232728T1 (de) * 1998-03-03 2003-03-15 Dae Woong Pharma Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
IL149750A0 (en) 1999-12-28 2002-11-10 Kimberly Clark Co A wiper containing a controlled-release anti-microbial agent
EP1255640B1 (en) 1999-12-28 2008-05-21 Kimberly-Clark Worldwide, Inc. Controlled release anti-microbial wipe for hard surfaces
ES2280270T3 (es) 1999-12-28 2007-09-16 Kimberly-Clark Worldwide, Inc. Sistema indicador dependiente de la utilizacion para articulos absorbentes.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
WO2002036126A1 (en) * 2000-10-30 2002-05-10 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
ES2645930T3 (es) * 2003-01-03 2017-12-11 Supernus Pharmaceuticals, Inc. Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
ES2396051T3 (es) 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
US8202456B2 (en) 2006-11-13 2012-06-19 Kyorin Pharmaceutical Co., Ltd. Method for preparing sustained release tablet
KR20120003906A (ko) 2009-03-27 2012-01-11 교린 세이야꾸 가부시키 가이샤 염기성 첨가제를 함유하는 매트릭스형 서방성 제제
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
CN106456681B (zh) * 2014-06-10 2019-11-22 狮王株式会社 含有清酒酵母的片剂
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (enExample) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
PT86831B (pt) 1992-05-29
IE880545L (en) 1988-08-27
CN1023765C (zh) 1994-02-16
IE61419B1 (en) 1994-11-02
EP0280571A2 (en) 1988-08-31
HK125793A (en) 1993-11-19
NZ223619A (en) 1990-10-26
LV10184A (lv) 1994-10-20
DK175620B1 (da) 2004-12-27
DE3882739D1 (de) 1993-09-16
HU202747B (en) 1991-04-29
AR243376A1 (es) 1993-08-31
EG18523A (en) 1993-04-30
HUT46531A (en) 1988-11-28
ES2044825T1 (es) 1994-01-16
ZA881301B (en) 1989-10-25
AU604849B2 (en) 1991-01-03
CN88101062A (zh) 1988-09-07
ATE92309T1 (de) 1993-08-15
PH24358A (en) 1990-06-13
LV10184B (en) 1995-04-20
IL85538A0 (en) 1988-08-31
JPS63227519A (ja) 1988-09-21
CA1316110C (en) 1993-04-13
DE280571T1 (de) 1993-08-12
IL85538A (en) 1991-09-16
MX10558A (es) 1993-11-01
KR960005140B1 (ko) 1996-04-22
EP0280571A3 (en) 1989-01-04
DK98088D0 (da) 1988-02-25
DE3882739T2 (de) 1994-02-17
RU1831337C (ru) 1993-07-30
PT86831A (pt) 1988-03-01
JPH082793B2 (ja) 1996-01-17
KR880009639A (ko) 1988-10-04
DK98088A (da) 1988-08-28
EP0280571B1 (en) 1993-08-04
AU1219388A (en) 1988-09-01
UA18251A (uk) 1997-12-25
ES2044825T3 (es) 1994-11-16
CY1741A (en) 1995-02-17

Similar Documents

Publication Publication Date Title
GR930300027T1 (enExample)
IN170849B (enExample)
IN169580B (enExample)
IN171672B (enExample)
DE3879938D1 (enExample)
IN169637B (enExample)
IN168537B (enExample)
IN167077B (enExample)
AU6297286A (enExample)
AU6304186A (enExample)
AU6706986A (enExample)
IN172331B (enExample)
AU6743887A (enExample)
AU5631486A (enExample)
AU6818487A (enExample)
AU6862687A (enExample)
IN169019B (enExample)
AU7240387A (enExample)
IN171133B (enExample)
AU7311987A (enExample)
AU6271686A (enExample)
AU5525386A (enExample)
AU7807391A (enExample)
AU7342087A (enExample)
GR3006090T3 (enExample)